Victrex plc (VCT) - Net Assets

Latest as of September 2025: GBX431.20 Million GBX ≈ $52.46K USD

Based on the latest financial reports, Victrex plc (VCT) has net assets worth GBX431.20 Million GBX (≈ $52.46K USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX566.90 Million ≈ $68.98K USD) and total liabilities (GBX135.70 Million ≈ $16.51K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check VCT financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX431.20 Million
% of Total Assets 76.06%
Annual Growth Rate 14.3%
5-Year Change -15.73%
10-Year Change 10.82%
Growth Volatility 14.6

Victrex plc - Net Assets Trend (1994–2025)

This chart illustrates how Victrex plc's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Victrex plc for the complete picture of this company's asset base.

Annual Net Assets for Victrex plc (1994–2025)

The table below shows the annual net assets of Victrex plc from 1994 to 2025. For live valuation and market cap data, see VCT market cap overview.

Year Net Assets Change
2025-09-30 GBX431.20 Million
≈ $52.46K
-6.59%
2024-09-30 GBX461.60 Million
≈ $56.16K
-7.86%
2023-09-30 GBX501.00 Million
≈ $60.96K
+2.12%
2022-09-30 GBX490.60 Million
≈ $59.69K
-4.12%
2021-09-30 GBX511.70 Million
≈ $62.26K
+6.38%
2020-09-30 GBX481.00 Million
≈ $58.52K
+4.20%
2019-09-30 GBX461.60 Million
≈ $56.16K
-5.78%
2018-09-30 GBX489.90 Million
≈ $59.61K
+2.40%
2017-09-30 GBX478.40 Million
≈ $58.21K
+22.95%
2016-09-30 GBX389.10 Million
≈ $47.34K
+8.51%
2015-09-30 GBX358.60 Million
≈ $43.63K
+1.47%
2014-09-30 GBX353.40 Million
≈ $43.00K
+12.66%
2013-09-30 GBX313.70 Million
≈ $38.17K
+15.71%
2012-09-30 GBX271.10 Million
≈ $32.99K
+22.34%
2011-09-30 GBX221.60 Million
≈ $26.96K
+4.87%
2010-09-30 GBX211.30 Million
≈ $25.71K
+25.60%
2009-09-30 GBX168.23 Million
≈ $20.47K
+0.86%
2008-09-30 GBX166.79 Million
≈ $20.29K
+17.89%
2007-09-30 GBX141.48 Million
≈ $17.21K
+24.71%
2006-09-30 GBX113.45 Million
≈ $13.80K
+22.99%
2005-09-30 GBX92.25 Million
≈ $11.22K
+24.74%
2004-09-30 GBX73.95 Million
≈ $9.00K
+20.96%
2003-09-30 GBX61.14 Million
≈ $7.44K
+18.12%
2002-09-30 GBX51.76 Million
≈ $6.30K
+16.92%
2001-09-30 GBX44.27 Million
≈ $5.39K
+25.60%
2000-09-30 GBX35.24 Million
≈ $4.29K
+25.60%
1999-09-30 GBX28.06 Million
≈ $3.41K
+21.82%
1998-09-30 GBX23.03 Million
≈ $2.80K
+29.73%
1997-09-30 GBX17.75 Million
≈ $2.16K
+34.23%
1996-09-30 GBX13.23 Million
≈ $1.61K
+63.60%
1995-09-30 GBX8.09 Million
≈ $983.71
+18.31%
1994-09-30 GBX6.83 Million
≈ $831.50
--

Equity Component Analysis

This analysis shows how different components contribute to Victrex plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 8128.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (September 2025)

Component Amount Percentage
Retained Earnings GBX375.40 Million 86.60%
Common Stock GBX900.00K 0.21%
Other Comprehensive Income GBX-5.00 Million -1.15%
Other Components GBX62.20 Million 14.35%
Total Equity GBX433.50 Million 100.00%

Victrex plc Competitors by Market Cap

The table below lists competitors of Victrex plc ranked by their market capitalization.

Company Market Cap
Gold Pacific Co. Ltd
KQ:038530
$6.53 Million
ARIP Public Company Limited
BK:ARIP
$6.54 Million
Kontigo Care AB
ST:KONT
$6.54 Million
Moolec Science SA Ordinary Shares
NASDAQ:MLEC
$6.55 Million
Tribe Property Technologies Inc
V:TRBE
$6.51 Million
Bullfrog AI Holdings, Inc. Common Stock
NASDAQ:BFRG
$6.51 Million
Effnetplattformen Holding AB
ST:EFFH
$6.51 Million
Spineway
PA:ALSPW
$6.50 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Victrex plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 461,000,000 to 433,500,000, a change of -27,500,000 (-6.0%).
  • Net income of 27,800,000 contributed positively to equity growth.
  • Dividend payments of 51,800,000 reduced retained earnings.
  • New share issuances of 100,000 increased equity.
  • Other comprehensive income decreased equity by 5,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX27.80 Million +6.41%
Dividends Paid GBX51.80 Million -11.95%
Share Issuances GBX100.00K +0.02%
Other Comprehensive Income GBX-5.00 Million -1.15%
Other Changes GBX1.40 Million +0.32%
Total Change GBX- -5.97%

Book Value vs Market Value Analysis

This analysis compares Victrex plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 124.64x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 6306.78x to 124.64x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1994-09-30 GBX0.10 GBX616.00 x
1995-09-30 GBX0.12 GBX616.00 x
1996-09-30 GBX0.18 GBX616.00 x
1997-09-30 GBX0.23 GBX616.00 x
1998-09-30 GBX0.29 GBX616.00 x
1999-09-30 GBX0.36 GBX616.00 x
2000-09-30 GBX0.45 GBX616.00 x
2001-09-30 GBX0.55 GBX616.00 x
2002-09-30 GBX0.65 GBX616.00 x
2003-09-30 GBX0.76 GBX616.00 x
2004-09-30 GBX0.91 GBX616.00 x
2005-09-30 GBX1.14 GBX616.00 x
2006-09-30 GBX1.39 GBX616.00 x
2007-09-30 GBX1.72 GBX616.00 x
2008-09-30 GBX2.03 GBX616.00 x
2009-09-30 GBX2.03 GBX616.00 x
2010-09-30 GBX2.52 GBX616.00 x
2011-09-30 GBX2.63 GBX616.00 x
2012-09-30 GBX3.21 GBX616.00 x
2013-09-30 GBX3.70 GBX616.00 x
2014-09-30 GBX4.15 GBX616.00 x
2015-09-30 GBX4.20 GBX616.00 x
2016-09-30 GBX4.56 GBX616.00 x
2017-09-30 GBX5.58 GBX616.00 x
2018-09-30 GBX5.68 GBX616.00 x
2019-09-30 GBX5.34 GBX616.00 x
2020-09-30 GBX5.52 GBX616.00 x
2021-09-30 GBX5.85 GBX616.00 x
2022-09-30 GBX5.60 GBX616.00 x
2023-09-30 GBX5.70 GBX616.00 x
2024-09-30 GBX5.24 GBX616.00 x
2025-09-30 GBX4.94 GBX616.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Victrex plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 6.41%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 9.38%
  • • Asset Turnover: 0.52x
  • • Equity Multiplier: 1.31x
  • Recent ROE (6.41%) is below the historical average (28.54%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1994 78.34% 22.47% 0.98x 3.58x GBX4.59 Million
1995 83.27% 21.23% 1.38x 2.85x GBX5.84 Million
1996 69.86% 24.34% 1.44x 1.99x GBX7.92 Million
1997 47.84% 19.56% 1.37x 1.79x GBX6.72 Million
1998 40.98% 19.96% 1.21x 1.70x GBX7.14 Million
1999 33.03% 19.97% 1.04x 1.59x GBX6.46 Million
2000 34.10% 20.46% 0.95x 1.75x GBX8.49 Million
2001 34.71% 21.31% 1.13x 1.44x GBX10.94 Million
2002 24.84% 21.76% 0.75x 1.51x GBX7.68 Million
2003 24.91% 21.30% 0.87x 1.35x GBX9.12 Million
2004 25.98% 22.19% 0.84x 1.39x GBX11.81 Million
2005 25.91% 23.68% 0.79x 1.39x GBX14.68 Million
2006 28.06% 25.99% 0.74x 1.47x GBX20.49 Million
2007 25.74% 27.80% 0.68x 1.37x GBX22.27 Million
2008 23.43% 27.69% 0.63x 1.34x GBX22.39 Million
2009 10.60% 17.18% 0.47x 1.31x GBX1.02 Million
2010 25.56% 28.50% 0.68x 1.32x GBX32.87 Million
2011 32.13% 32.99% 0.75x 1.30x GBX49.04 Million
2012 26.52% 32.71% 0.67x 1.20x GBX44.79 Million
2013 23.24% 32.85% 0.60x 1.17x GBX41.53 Million
2014 22.69% 31.75% 0.61x 1.18x GBX44.86 Million
2015 23.28% 31.69% 0.62x 1.19x GBX47.64 Million
2016 21.20% 32.70% 0.53x 1.21x GBX43.59 Million
2017 20.80% 34.29% 0.54x 1.12x GBX51.66 Million
2018 22.58% 33.93% 0.58x 1.15x GBX61.61 Million
2019 20.02% 31.43% 0.55x 1.16x GBX46.24 Million
2020 11.34% 20.38% 0.48x 1.15x GBX6.39 Million
2021 14.38% 23.90% 0.50x 1.21x GBX22.28 Million
2022 15.59% 22.35% 0.53x 1.31x GBX27.32 Million
2023 12.36% 20.10% 0.49x 1.26x GBX11.80 Million
2024 3.73% 5.81% 0.50x 1.28x GBX-28.90 Million
2025 6.41% 9.38% 0.52x 1.31x GBX-15.55 Million

Industry Comparison

This section compares Victrex plc's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $249,610,221
  • Average return on equity (ROE) among peers: -8.61%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Victrex plc (VCT) GBX431.20 Million 78.34% 0.31x $6.53 Million
Biome Technologies Plc (BIOM) $22.86 Million 0.61% 0.46x $62.73K
Croda International PLC (CRDA) $141.90 Million 17.12% 0.88x $48.13 Million
Directa Plus PLC (DCTA) $-1.89 Million 0.00% 0.00x $85.76K
Elementis PLC (ELM) $762.40 Million 20.92% 1.52x $10.19 Million
Essentra PLC (ESNT) $270.80 Million 3.91% 0.82x $2.83 Million
Haydale Graphene Industries (HAYD) $6.60 Million -54.51% 0.17x $174.89K
Hardide PLC (HDD) $7.70 Million -14.76% 0.25x $359.60K
Iofina plc (IOF) $25.77 Million -10.28% 0.09x $968.76K
Itaconix plc (ITX) $9.17 Million -62.28% 0.09x $176.39K
Johnson Matthey PLC (JMAT) $1.25 Billion 13.13% 1.31x $42.28 Million

About Victrex plc

LSE:VCT UK Specialty Chemicals
Market Cap
$6.53 Million
GBX53.64 Billion GBX
Market Cap Rank
#27839 Global
#416 in UK
Share Price
GBX616.00
Change (1 day)
+2.16%
52-Week Range
GBX539.00 - GBX905.00
All Time High
GBX2680.46
About

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainabl… Read more